This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jazz Pharmaceuticals PLC (JAZZ)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 329.53M 57.33M 216.31M 288.59M
Operating Gains/Losses 16.99M 24.00K 3.79M -35.08M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -24.84M -55.04M -48.85M -4.72M
(Increase) Decrease in Inventories 6.27M -7.63M -8.52M 1.70M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -2.28M -37.97M 5.09M -7.29M
(Decrease) Increase In Other Current Liabilities -3.29M 14.73M -24.27M 27.91M
(Increase) Decrease In Other Working Capital 14.30M 7.63M 9.45M -9.66M
Other Non-Cash Items 121.95M 324.50M 72.47M 37.51M
Net Cash From Continuing Operations 531.94M 405.76M 283.62M 249.75M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 531.94M 405.76M 283.62M 249.75M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 93.92M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 31.99M
Purchases of Property, Plant & Equipment -35.96M -238.97M -11.28M -22.48M
Acquisitions 33.70M -828.68M 0.00 -542.53M
Purchases of Short-Term Investments 0.00 0.00 0.00 -37.44M
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -2.25M -1.07B -11.28M -395.29M
Issuance of Debt 898.64M 1.19B 0.00 450.92M
Cash Used for Financing Activities
Issuance of Capital Stock 40.52M 58.49M 30.70M 25.00M
Repayment of Long-Term Debt -905.76M -309.52M -465.91M -11.88M
Repurchase of Capital Stock -61.55M -42.22M -136.48M 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -186.18M -188.26M 547.66M -15.51M
Net Cash From Financing Activities -214.32M 712.88M -24.03M 448.53M
Effect of Exchange Rate Changes -10.62M -3.45M 997.00K 2.13M
Net Change in Cash & Cash Equivalents 304.74M 47.54M 249.31M 305.12M
JAZZ News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

JAZZ Jazz Pharmaceuticals PLC

Chart of JAZZ

Analysts Ratings for JAZZ

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 10 10 10
Moderate Buy 0 0 0 0
Hold 1 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET JAZZ ANALYST REPORT

JAZZ Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs